Gradient Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-45
Closed -$932 970
2024
Q2
$932 Sell
45
-29
-39% -$576 ﹤0.01% 1087
2024
Q1
$1.39K Sell
74
-257
-78% -$4.41K ﹤0.01% 872
2023
Q4
$4.77K Buy
331
+13
+4% +$177 ﹤0.01% 1006
2023
Q3
$5.52K Sell
318
-222
-41% -$4.63K ﹤0.01% 938
2023
Q2
$11.2K Sell
540
-35
-6% -$761 ﹤0.01% 796
2023
Q1
$13.5K Sell
575
-8
-1% -$215 ﹤0.01% 744
2022
Q4
$16.3K Sell
583
-158
-21% -$4.04K ﹤0.01% 728
2022
Q3
$17K Sell
741
-1
-0.1% -$30 ﹤0.01% 695
2022
Q2
$25K Sell
742
-29
-4% -$1.02K ﹤0.01% 604
2022
Q1
$27K Sell
771
-151
-16% -$5.16K ﹤0.01% 590
2021
Q4
$28K Buy
922
+6
+0.7% +$195 ﹤0.01% 595
2021
Q3
$30K Sell
916
-2,881
-76% -$92.2K ﹤0.01% 574
2021
Q2
$115K Buy
+3,797
New +$125K ﹤0.01% 347

Other funds holding OGN

Gradient Investments's OGN Position: Q3 2024 in Review

Gradient Investments sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 45 shares — an estimated $932 sold.

Gradient Investments first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $115K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Gradient Investments reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 45 Organon & Co shares in Q3 2024, an estimated $932.
  • Gradient Investments first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Gradient Investments's Organon & Co position peaked at $115K in Q2 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.